Transgenic CD1 mice expressing beta-galactosidase were used as myoblas
t donors. The myoblasts were injected in normal or mdx muscles previou
sly irradiated and injected with notexin. Twenty-eight days after myob
last transplantation, the percentage of muscle fibers beta-galactosida
se-positive was low in mice not immunosuppressed but was high (80%) in
those treated with FK506. In mdx mice, muscle fibers expressing beta-
galactosidase were also dystrophin positive. Most of the mice not trea
ted with FK506 produced antibodies against the donor myoblasts. These
results indicate that FK506 is a very useful immunosuppressive drug fo
r myoblast transplantation in mice. Irradiation and notexin injection
used in our experiments are, however, not feasible in humans. Other ma
nipulations capable of increasing the participation of donor myoblasts
to regeneration will therefore have to be identified before new clini
cal trials are attempted. (C) 1994 John Wiley & Sons, Inc.